The female libido pill is no Viagra | Bloomberg
Just a few hundred prescriptions were filled nationwide for Valeant's female-libido pill Addyi in the first two weeks of availability. A restriction on alcohol consumption, a $780-per-month price tag, and doc-certification requirements that have limited the number of current prescribers to about 1% of physicians may be dampening sales.
Privacy not included: Federal law lags behind new tech | ProPublica
With direct-to-consumer health-testing and -monitoring technology proliferating, Americans are offering their personal data up to entities they may not be aware are not covered or bound by state or federal privacy laws.
New diagnostic tools emerge in war against superbugs | Wall Street Journal
Several companies are developing diagnostic tests to better and more rapidly pinpoint the causes of infections. The hope is that treatment can be more carefully targeted, reducing antibiotic overuse.
Reported cases of STDs on the rise in the U.S. | Centers for Disease Control and Prevention
Chlamydia, gonorrhea and syphilis are on the rise for the first time since 2006, according to the CDC's 2014 STD Surveillance report (PDF). Cases of chlamydia reached a record high with 1.4 million Americans diagnosed last year. The report also noted a significant increase in syphilis infections among gay and bisexual men.
Texas law leads to more attempts at self-induced abortion: study | Reuters
A Texas law that tightened restrictions on abortion providers and facilities reduced clinical abortions but also led an estimated 100,000 to 240,000 women to try self-induced abortions, a new study reports.
Guinea says no Ebola cases after last patient recovers | Reuters
The last Ebola patient in Guinea, an infant less than a month old, left the hospital on Monday, beginning that country's 42-day countdown to being declared officially Ebola-free.
